C.R. Bard, Inc.: Medical Device Recall in 2017 - (Recall #: Z-0267-2018)

Updated on March 25, 2026.

See the recall detail below. You can also see other recalls from the same firm in 2017.

Data Source: FDA.

Product Description:

I-125 CE Marked QuickLink Cartridges; Sterile; Bard Brachysource Radioactive Seeds in QuickLink Cartridges Indicated for permanent interstitial treatment of selected localized tumors such as: head and neck, lung, pancreas, and early stage prostate. Implants are indicated to treat residual tumors following completion of a course of external radiation therapy and for recurrent tumors.

Product Classification:

Class II

Date Initiated: December 9, 2016

Date Posted: December 27, 2017

Recall Number: Z-0267-2018

Event ID: 77439

Reason for Recall:

Activity and quantity of seeds sent in shipments were incorrect.

Status: Terminated

Product Quantity: 134 seeds

Code Information:

Product Code: 1251QCSCE, Lot No. BBAY0072, BBAY0079, BBAY0090, BBAY0071, BBAY0073.

Distribution Pattern:

Belgium & South Africa.

Voluntary or Mandated:

Voluntary: Firm initiated